Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Muller-Steffner, H. M.
Right arrow Articles by Schuber, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Muller-Steffner, H. M.
Right arrow Articles by Schuber, F.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 271, Number 39, Issue of September 27, 1996 pp. 23967-23972
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

Mechanism of Cyclization of Pyridine Nucleotides by Bovine Spleen NAD+ Glycohydrolase*

(Received for publication, April 17, 1996, and in revised form, July 17, 1996)

Hélène M. Muller-Steffner , Angélique Augustin and Francis Schuber Dagger

From the Laboratoire de Chimie Bioorganique, Laboratoire Associé au Centre National de la Recherche Scientifique 1386, Faculté de Pharmacie, Université Louis Pasteur Strasbourg, 74 route du Rhin, 67400 Illkirch, France

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
Acknowledgments
REFERENCES


ABSTRACT

We have shown that bovine spleen NAD+ glycohydrolase (EC), purified to homogeneity, is a multifunctional enzyme. A time-dependent formation of cADPR from NAD+ that did not exceed 1.5-2% of the reaction products was measurable. The cyclase activity of this enzyme was, however, best evidenced by its transformation of NGD+ into cyclic GDP-ribose (cGDPR). The formation of the cyclic compound could be monitored spectroscopically (UV and fluorescence) and by high-performance liquid chromatography; the product ratio of cGDPR/GDP-ribose was 2:1. Bovine spleen NAD+ glycohydrolase is also able to hydrolyze cADPR (Muller-Steffner et al. (1994) Biochem. Biophys. Res. Commun. 204, 1279-1285); the kinetic parameters (V/Km) measured exclude, however, the possibility that cADPR is a kinetically competent reaction intermediate in the transformation of NAD+ into ADP-ribose. Experimental data indicating that NAD+ glycohydrolase-catalyzed hydrolysis and methanolysis of NA(G)D+ occurred at the expense of the formation of the cyclic compounds are in favor of a reaction mechanism involving the partitioning of a common oxocarbenium reaction intermediate between the different acceptors. Thus E·A(G)DP-ribosyl oxocarbenium intermediate can react according to i) intramolecular processes with the positions N-1 of adenine and N-7 of guanine to give cA(G)DPR as reaction products, and ii) intermolecular reactions with water (formation of A(G)DP-ribose) and methanol (formation of methyl A(G)DP-ribose). We attribute the marked difference in yield of cADPR and cGDPR to the intrinsic reactivity (nucleophilicity and positioning) of the purine N-positions that are involved in the cyclization reactions within the E·A(G)DP-ribosyl oxocarbenium complexes.


INTRODUCTION

Cyclic ADP-ribose, which was originally discovered in sea urchin eggs, is thought to be the endogenous regulator of the Ca2+-induced Ca2+-release process mediated by the ryanodine receptors (reviewed in Lee et al., 1994). In invertebrates, this new metabolite is the exclusive reaction product obtained from NAD+ by an ADP-ribosyl cyclase (Lee and Aarhus, 1991; Hellmich and Strumwasser, 1991). In mammalian tissues no equivalent enzyme could be detected; however, a high sequence homology was found between the cyclase from Aplysia californica and CD38, a human lymphocyte cell surface antigen, for which no biological activity was hitherto known (States et al., 1992). CD38 revealed itself to be a multifunctional enzyme; i.e. in addition to catalyzing the hydrolytic cleavage of NAD+ into ADP-ribose, it was also able to produce cADPR,1 albeit in small amounts (less than 2-3% of reaction products), and to hydrolyze cADPR into ADP-ribose (Howard et al., 1993). Similar catalytic activity had previously been established for a canine spleen enzyme that had the characteristics of a NAD+ glycohydrolase (Kim et al., 1993a). The low yield of cADPR production by these mammalian systems was attributed to their multifunctionality: the cyclic metabolite does not accumulate because it is turned over by the same enzyme that produces it (Kim et al., 1993a; Lee, 1994; Lee et al., 1995). In apparent agreement with this hypothesis, it was established by Graeff et al. (1994) that NGD+, an analogue of NAD+, is converted in high yield by CD38 into cyclic GDP-ribose, a metabolite that cannot be further transformed.

Since the occurrence of CD38 was originally thought to be restricted to B and T lymphocytes (Malavasi et al., 1994; Lund et al., 1995) and erythrocytes (Zocchi et al., 1993), it was of interest to broaden the issue of the biosynthesis of cADPR in mammalian systems by investigating the possible contribution of the classical NAD(P)+ glycohydrolases (EC and 3.2.2.6). These enzymes have been known for several decades and they have a wider tissular and cellular distribution than CD38 (Price and Pekala, 1987). We have been engaged for many years in the study of the molecular mechanism of bovine spleen NAD+ glycohydrolase and have shown conclusively that this enzyme catalyzes a dissociative mechanism; i.e. the nicotinamide-ribose bond is cleaved to generate an enzyme-stabilized oxocarbenium ion-type intermediate that reacts in a non-rate-limiting step with acceptors such as water (hydrolysis), methanol (methanolysis), or pyridines (transglycosidation) (Schuber et al., 1979; Tarnus and Schuber, 1987; Tarnus et al., 1988; Handlon et al., 1994). Recently we have also shown that this enzyme was able to hydrolyze cADPR into ADP-ribose; the measured kinetic parameters, however, excluded the possibility that cADPR is a kinetically competent reaction intermediate in the conversion of NAD+ into ADP-ribose (Muller-Steffner et al., 1994).

In the present study we provide evidence that bovine spleen NAD+ glycohydrolase can cyclize NGD+ into cGDPR in high yields and that the low net conversion of NAD+ into cADPR is not due to a fast turnover that prevents it from accumulating but to a lesser reactivity of the adenine ring, compared to guanine, with the intermediary oxocarbenium ion.


EXPERIMENTAL PROCEDURES

Chemicals

NAD+, NGD+ and CHAPS were from Sigma. [adenine-U-14C]NAD+ (604 Ci/mol) was from NEN DuPont (France). cADPR and cGDPR were prepared by incubating respectively NAD+and NGD+ with Aplysia ADP-ribosyl cyclase and were purified by HPLC.

Enzymes

ADP-ribosyl cyclase from A. californica was from Sigma. NAD+ glycohydrolase (with a specific activity of 180 U/mg protein) was solubilized from calf spleen microsomes and purified as described previously (Muller-Steffner et al., 1993).

Transformation of NGD+ by NAD+ Glycohydrolase

The conversion of NGD+ into cGDPR was followed by two continuous assays (Graeff et al., 1994): (i) spectrophotometrically, by monitoring the increase in absorbance at 300 nm, and (ii) fluorometrically, by monitoring the increase in fluorescence at 410 nm (excitation at 300 nm). To that end, NGD+ (final concentration, 100 µM) was incubated at 37 °C in a 10 mM potassium phosphate buffer, pH 7.4, containing 0.5% (w/v) CHAPS, in the presence of 50 milliunits of NAD+ glycohydrolase (1 ml final volume).

Analysis of the Reaction Products by HPLC

Product analysis was performed on aliquots of the reaction medium by using a Waters HPLC system. Chromatography was carried out on a 300 × 3.9 mm µBondapak C18 column (Waters) operated at ambient temperature, at a flow rate of 1 ml/min. The compounds were eluted isocratically with a 10 mM ammonium phosphate buffer, pH 5.5, containing 1.2% (v/v) acetonitrile and detected by their UV absorbance at 260 nm or by radiodetection (Flow-one, Packard Instruments). Peak areas were integrated and those obtained from UV recordings were normalized, using calibration curves, to take into account the differences in the molar extinction coefficients of the reaction products.

Determination of the Kinetic Parameters of NGD+

NGD+ (final concentrations, 10-200 µM) was incubated at 37 °C in a 10 mM potassium phosphate buffer, pH 7.4, containing 0.5% (w/v) CHAPS in the presence of 6 milliunits of NAD+ glycohydrolase (500 µl final volume). Aliquots were withdrawn at given time intervals and analyzed by HPLC to determine the percentage of cGDPR and GDPR formed as a function of time. For each substrate concentration, the initial rate was calculated from the progress curve using a polynomial regression analysis (Knowles, 1965). The kinetic parameters were obtained from the plot of the initial rates as a function of substrate concentrations, using a nonlinear regression program.

Methanolysis of NGD+ by NAD+ Glycohydrolase

In the nonenzymatic experiment, NGD+ (100 µM; final volume, 1 ml) was incubated at 80 °C in 25 mM sodium phosphate buffer, pH 7.0, containing 30% (v/v) methanol (final concentration, 7.41 M). In the enzymatic experiment, NGD+ (100 µM; final volume, 1 ml) was incubated at 37 °C in a 10 mM potassium phosphate buffer, pH 7.4, containing 0.5% (w/v) CHAPS and increasing concentrations of methanol (0, 1, 2, and 3 M) in the presence of 50 milliunits of NAD+ glycohydrolase. Reaction progress was followed spectrophotometrically at 300 nm. In both enzymatic and nonenzymatic reactions, product analysis was obtained on aliquots by HPLC as described above.

Conversion of NAD+ into cADPR by NAD+ Glycohydrolase

NAD+ (final concentration, 50 µM, containing 106 dpm [14C]NAD+) was incubated at 37 °C in a 10 mM potassium phosphate buffer, pH 7.4, containing 0.5% (w/v) CHAPS, in the presence of 5 milliunits of NAD+ glycohydrolase (final volume, 1 ml). Aliquots were removed at time intervals and analyzed by HPLC. The eluted compounds were detected by their UV absorbance at 260 nm and the radioactivity was monitored in parallel with a radiochemical detector (Flow-one, Packard).

Nonenzymatic hydrolysis of cADPR and cGDPR

Monomolecular decomposition of cADPR and cGDPR was studied in 50 mM sodium phosphate buffer (pH 6.0) at 80 °C. Aliquots were analyzed at different times by HPLC and a single reaction product was formed (i.e. A(G)DP-ribose) for at least 3-4 half-lives. The observed pseudo-first order rate constants were calculated using normalized peak areas.


RESULTS

Cyclization of NGD+ Catalyzed by Calf Spleen NAD+ Glycohydrolase

NGD+, which, compared to NAD+, is converted in much higher yields into a cyclic derivative by CD38, is a convenient tool with which to study mammalian ADP-ribosyl cyclases (Graeff et al., 1994). It should be noted that the structure of cyclic GDP-ribose was recently reassessed and that the cyclization involves the N-7 position of the purine ring as opposed to the N-1 position in the formation of cADPR (Zhang and Sih, 1995; Graeff et al., 1996). The transformation of NGD+ into cyclic GDP-ribose, which can be conveniently followed by the spectral characteristics of the cyclic compound (Graeff et al., 1994, 1996), was tested with calf spleen NAD+ glycohydrolase. When NGD+ was incubated in the presence of the enzyme, an increase of absorbance at 300 nm was monitored as a function of time (not shown), which is indicative of the formation of cGDPR. The cyclization reaction was also established by measuring the increase of fluorescence at 410 nm (Fig. 1); the progress curves reached a plateau and further addition of NAD+ glycohydrolase (up to 50 milliunits) did not produce a change in fluorescence, indicating that under these experimental conditions the fluorescent reaction product is not turned over. Production of cyclic GDP-ribose was estimated by analyzing the reaction products by HPLC. The elution profiles obtained, which are similar to those described in literature with CD38 (Graeff et al., 1994), showed that NAD+ glycohydrolase converted NGD+ into cyclic GDP-ribose and GDP-ribose (Fig. 2A) in a 2:1 ratio in favor of the cyclic compound (Table I). The peak attributed to cyclic GDP-ribose was collected and authenticated by its fluorescence spectra (not shown). From these experiments, we can conclude that calf spleen NAD+ glycohydrolase is able to efficiently catalyze the conversion of NGD+ into cGDPR and is therefore a member of the class of mammalian enzymes that includes CD38 and BST-1 (Hirata et al., 1994), which catalyze the cyclization of dinucleotides.


Fig. 1. Fluorescence assay for the cyclization of NGD+ catalyzed by bovine spleen NAD+ Glycohydrolase. The enzyme (50 milliunits) was incubated at 37 °C with NGD+ (100 µM) in 10 mM potassium phosphate buffer (pH 7.4) containing 0.5% (w/v) CHAPS (final volume, 1 ml). The progress curve represents the increase in fluorescence emission measured at 410 nm (excitation at 300 nm). Inset, double-reciprocal representation of rate of NGD+ transformation in the presence of 6 milliunits NAD+ glycohydrolase versus substrate concentration (10-200 µM). Initial rates were calculated from progress curves obtained by HPLC analysis on aliquots of the reaction mixture (see ``Experimental Procedures'').
[View Larger Version of this Image (23K GIF file)]


Fig. 2. HPLC elution profile of the products obtained by incubation of NGD+ with NAD+ glycohydrolase. NGD+ (100 µM) was incubated for different time periods at 37 °C in a 10 mM potassium phosphate buffer (pH 7.4) containing 0.5% (w/v) CHAPS and 6 milliunits of enzyme, in the absence (A) or presence (B) of 3 M methanol. HPLC analyses were obtained on a reverse-phase µBondapak C18 column (see ``Experimental Procedures''). a, cGDP-ribose; b, GDP-ribose; c, methyl GDP-ribose; d, NGD+; e, nicotinamide.
[View Larger Version of this Image (14K GIF file)]

Table I.

Transformation of NGD+ by NAD+ glycohydrolase: competition between the reaction of cyclization and the reactions of methanolysis and hydrolysis

NGD+ (100 µM) was incubated at 37 °C in a 10 mM potassium phosphate buffer, pH 7.4, containing 0.5% (w/v) CHAPS and increasing concentrations of methanol in the presence of 50 milliunits of enzyme. Aliquots were analyzed by HPLC as described under ``Experimental Procedures'' and peak areas of the reaction products were normalized.
Methanol (cGDP-ribose)/(GDP-ribose) + (methyl GDP-ribose)

m
0 2.10
0.5 1.34
1 1.12
2 0.59
3 0.36

Kinetic parameters of the transformation of NGD+ by NAD+ glycohydrolase were calculated from the reaction rates obtained from the HPLC profiles (Fig. 1, inset). The Km of bovine NAD+ glycohydrolase for NGD+ was estimated to be 24 µM, which is equivalent to that of NAD+ (26.2 ± 3.6 µM under the same experimental conditions). The Vm of the enzyme for NGD+ was 80 µmol/min/mg of protein. When considering NGD+ and NAD+ as competing substrates for the active site of calf spleen NAD+ glycohydrolase, the ratio of their specificity constants V/Km (i.e. 3.3 and 6.9 liters/min/mg protein respectively) is about 2:1 in favor of NAD+. It appears, therefore, that NGD+ is an excellent substrate for bovine NAD+ glycohydrolase and that the only difference between this dinucleotide and NAD+ lies in the products generated during enzymatic catalysis.

Conversion of NAD+ into Cyclic ADP-ribose by Calf Spleen NAD+ Glycohydrolase

Because of the ability of NAD+ glycohydrolase to catalyze the conversion of NGD+ into cyclic GDP-ribose, we have reassessed the formation of cADPR from NAD+, which we had previously estimated to be very low (Muller-Steffner et al., 1994). Thus [14C]NAD+ was incubated in the presence of the enzyme and the reaction products were analyzed by HPLC using on-line UV and radioactivity detectors. The main product was ADP-ribose, but we could establish the formation, albeit in low amounts, of a product presenting an elution time identical, both by UV and radioactivity, to that of c[14C]ADPR. The formation of this product was time-dependent (Fig. 3) and it amounted to about 1.5% (± 0.3%; n = 6) of the products formed. In control experiments (boiled enzyme), no such peak appeared; moreover, the formation of cADPR became undetectable when the reaction was run in the presence of 3 M methanol (see below). Such a low percentage for the formation of cADPR is very similar to the values found for example for CD38 (Howard et al., 1993).


Fig. 3. Formation of ADP-ribose and cyclic ADP-ribose from NAD+ catalyzed by bovine spleen NAD+ glycohydrolase. NAD+ (50 µM) and 106 dpm [adenine-U-14C]NAD+ were incubated at 37 °C in a 10 mM potassium phosphate buffer (pH 7.4) containing 0.5% (w/v) CHAPS in the presence of 5 milliunits of enzyme. Aliquots were removed at given time intervals and analyzed by HPLC as described under ``Experimental Procedures.'' Quantitative estimates (given as percentage of total radioactivity) for the formation of ADP-ribose (bullet ) and cADPR (black-square) were obtained from the radiochromatograms. Note the difference in scale for the formation of cADPR.
[View Larger Version of this Image (14K GIF file)]

Methanolysis of NGD+ Catalyzed by Calf Spleen NAD+ Glycohydrolase

The important difference in the formation of cADPR and cGDPR, by CD38 and other cyclases, is generally attributed to the ``multifunctionality'' of such enzymes and to the fast turnover of cADPR as opposed to the poor hydrolysis of cGDPR. Such an analysis was not borne out, at least for calf spleen NAD+ glycohydrolase; the Km value for the hydrolysis of cADPR is 2 orders of magnitude higher than NAD+ (Muller-Steffner et al., 1994), indicating that the cyclic metabolite, if released from the active site of the enzyme, should accumulate during the transformation of NAD+. Therefore, since our analysis of the reaction catalyzed by this enzyme points to the formation, during the slow step of the reaction process, of a stabilized oxocarbenium ion reaction intermediate, we reasoned that the formation of the reaction products is dependent on the ability of the different acceptors to react with this intermediate. Thus, depending on the substrate used, the intermediary oxocarbenium ion might react with water, leading to A(G)DP-ribose, but also with N-7 of the guanine ring, yielding cGDPR, and with the N-1-position of the adenine to give cADPR, this latter process being unfavorable (Fig. 4).


Fig. 4. Partitioning of the oxocarbenium intermediate occurring in the reaction catalyzed by bovine spleen NAD+ glycohydrolase. The enzyme-stabilized oxocarbenium intermediates generated from NA(G)D+ during the rate-limiting step undergo intramolecular cyclization reactions involving the attack by the positions N-1 of adenine and N-7 of guanine. The formation of cADPR (minor pathway) and cGDPR are in competition with the intermolecular reaction of the intermediate with water (formation of A(G)DPR) and methanol (formation of methyl A(G)DPR), respectively. The low amount of cADPR formed by the enzyme, compared to cGDPR, is proposed to be related to a lower rate of intramolecular reaction, which might be ascribed to a combination of a lower nucleophilicity of the N-1 of adenine, compared to N-7 of guanine, and/or a less favorable configuration of the adenine ring for cyclization.5
[View Larger Version of this Image (14K GIF file)]

To verify this hypothesis, which implies that these different acceptors compete for the same oxocarbenium ion, we decided to perform the reaction in presence of methanol. We have previously demonstrated that the oxocarbenium intermediate formed during the NAD+ glycohydrolase-catalyzed transformation of NAD+ reacts about 50-fold faster with methanol than with water (Tarnus et al., 1988). Methyl ADP-ribose is formed with retention of configuration, and in the presence of high enough concentrations of methanol, it becomes the preponderant reaction product. Thus, if a similar water/methanol partitioning ratio is found in the transformation of NGD+, one should observe the formation of methyl GDP-ribose at the expense of cGDPR.

Transformation of NGD+ catalyzed by calf spleen NAD+ glycohydrolase in the presence of increasing concentrations of methanol was analyzed by HPLC. In the presence of this acceptor, a new reaction product was formed (Fig. 2B) whose retention time was identical to one of the methyl GDR-ribose isomers obtained by spontaneous solvolysis of NGD+ in presence of 30% (v/v) methanol.2 Analysis of the data indicated that, similarly to NAD+, the partitioning ratio3 was 52.4 (± 4.6; n = 6) in favor of methanolysis. As indicated in Table I, increasing concentrations of methanol led to increased formation of methyl GDP-ribose, at the expense of cGDPR; this demonstrates that methanolysis, as expected from our hypothesis, competes with the cyclization process. It was also found that addition of methanol did not increase the turnover of NGD+, confirming that the reaction of the oxocarbenium ion with acceptors is a fast step in the catalytic process of NAD+ glycohydrolase relative to the formation of this intermediate (Schuber et al., 1976). Importantly, in control experiments performed with the same concentration of enzyme and using a continuous fluorometric assay, NAD+ glycohydrolase was found to be unable to transform cGDPR even in the presence of the highest concentrations of methanol used above.

Nonenzymatic Hydrolysis of cADPR and cGDPR

The nonenzymatic hydrolysis of cADPR and cGDPR was studied in phosphate buffer at pH 6.0. Under these experimental conditions, where pyridinium analogues of NAD+ are hydrolyzed according to a monomolecular mechanism (Tarnus and Schuber, 1987), the N-1-position of the adenosine moiety of cADPR should be fully positively charged (Kim et al., 1993b), as is N-7 in cGDPR,4 and be a reasonably good leaving group. Hydrolyses followed pseudo-first order kinetics, and kobs was measured at 0.057 and 0.0115 min-1 (at 80 °C) for cADPR and cGDPR, respectively. Thus, cADPR is hydrolyzed about 5-fold faster than cGDPR.


DISCUSSION

The mode of formation of cyclic ADP-ribose by mammalian systems and its relevance to the mobilization of intracellular Ca2+ is still under intense study (Lee et al., 1994). In this communication, we have shown that the ``classical'' bovine spleen NAD+ glycohydrolase is able to catalyze the transformation of NAD+ into ADP-ribose (its classical hydrolytic reaction) and into a small fraction of cADPR (less than 2%). The cyclase activity of this enzyme was much better evidenced when using NGD+ as substrate, where cGDPR represented the major reaction product. Moreover, as shown previously, this NAD+ glycohydrolase is also able to hydrolyze cADPR into ADP-ribose (Muller-Steffner et al., 1994), but in contrast does not readily convert cGDPR into GDP-ribose. Altogether, bovine spleen NAD+ glycohydrolase shares with CD38 (Howard et al., 1993) and a recently described canine spleen NAD+ glycohydrolase (Kim et al., 1993a) the different catalytic activities that are involved in the metabolism of cADPR. Such a result, of course, raises the question of the identity and/or the differences in tissular localization and functions between CD38 and NAD+ glycohydrolases. Although it recently became apparent that the distribution of CD38 is somewhat wider than was previously believed (Funaro et al., 1995), it should be emphasized that NAD+ glycohydrolases are found associated with cells such as Kupffer cells in liver (Amar-Costesec et al., 1985) and microglial cells (Bocchini et al., 1988) and with organelles such as mitochondria (Masmoudi and Mandel, 1987), where no CD38 has been reported so far.

An important issue is the very low production of cADPR by the mammalian enzymes, as compared to the invertebrate ADP-ribosyl cyclases. This was attributed to the absence of accumulation of the cyclic metabolite because of its fast hydrolysis by the very same enzyme that produces it. Several mechanisms have been published to explain that point (Kim et al., 1993a; Lee et al., 1995; Graeff et al., 1996), and since the outcome of the reaction catalyzed by NAD+ glycohydrolases is that of an ADP-ribosyl cyclase coupled to an cADPR hydrolase, it has been proposed that these enzymes, for which no physiological roles had been found so far, were similar to CD38; i.e. enzymes whose multifunctionality had been overlooked. If from our studies it seems obvious that classical mammalian NAD+ glycohydrolases are indeed multifunctional, their very low production of cADPR from NAD+ cannot be attributed to a fast hydrolysis of this cyclic metabolite into ADP-ribose. On the contrary, as shown in this study, the very limited capacity of calf spleen NAD+ glycohydrolase to generate cADPR is a direct consequence of the reaction mechanism of the enzyme. We have conclusively demonstrated that the cyclization reactions, which involve the N-1-position of adenine and the N-7-position of guanine in NAD+ and NGD+, respectively, are in competition with the nucleophilic attack of a common intermediary oxocarbenium ion by a water molecule that yields A(G)DP-ribose (Fig. 4). A question is raised about the origin of such a marked difference in the extent of cADPR and cGDPR formation. It is well known that in adenine the most nucleophilic position is N-1, whereas in guanine it is N-7 (Jones and Robins, 1963; Singer, 1975); it is therefore probably not a coincidence that the cyclic compounds that are formed are precisely the ones that involve these nucleophilic centers in the purine rings. Moreover, the fact that 1,N6-etheno-NAD+, whose N-1 is masked, is also cyclized at position N-7 (Zhang and Sih, 1995; Graeff et al., 1996) indicates that in the active site of these enzymes, the purine rings do not have a fixed binding pattern. It appears therefore that the differences in the formation in cADPR and cGDPR in this intramolecular cyclization reaction might reflect the differences in nucleophilicity of the two nitrogens in the active site of the enzyme; indeed, it is well known that in many reactions involving the alkylation of bases, N-7 of the guanine ring is more nucleophilic than N-1 of adenine (Brown, 1974; Singer, 1975; Beranek et al., 1980). Interestingly, a high sensitivity of NAD+ glycohydrolases to the nucleophilicity of attacking pyridines, which yield by transglycosidation pyridinium analogues of NAD+, has been noted before (Yost and Anderson, 1983; Tarnus and Schuber, 1987).

Since the hydrolysis of the cyclic compounds by NAD+ glycohydrolase is also expected to yield an intermediary oxocarbenium ion (Muller-Steffner et al., 1994), the observation that cADPR is hydrolyzed much better than cGDPR is, on the first analysis, in good agreement with our previous studies, which demonstrated a very high dependence of the rate of such reactions on the pKa of the leaving group (beta lg = -0.9) and an excellent correlation with the chemical stability of the pyridinium-ribose bond (Tarnus and Schuber, 1987). Under unimolecular hydrolysis conditions (pH 6.0), however, the half-life of cGDPR is only about 5-fold higher than that of cADPR, indicating that the difference in energy of their scissile bonds is not as important as anticipated from their behavior as substrates of NAD+ glycohydrolase. It seems, therefore, that other factors are of importance in explaining such differences, which might be related to e.g. the mode of binding of cADPR and cGDPR to the active site of the enzyme. Moreover, since the energy of the ribose-nitrogen bonds in cA(G)DPR also reflects the nucleophilicity of the N-1 and N-7 positions in the adenine and guanine moieties during the enzyme-catalyzed cyclization reactions, the much favored formation of cGDPR might also indicate the occurrence of additional factors, such as e.g. a better positioning, within the active site, of the guanine with respect to the reaction with the oxocarbenium ion (Fig. 4). Interestingly, during the enzyme-catalyzed cyclization step, the attacking purine rings must adopt opposite configurations, i.e. syn and anti for cADPR and cGDPR, respectively, which are the less favored in solution.

The fact that NAD+ glycohydrolase is an efficient GDP-ribosyl cyclase and hydrolyzes cADPR is also an important indication with regard to the conformation of the substrates when bound to its active site. In contrast to toxins (Bell and Eisenberg, 1996) and to oxidoreductases having a ``Rossmann fold'' (Rossmann et al., 1975), where NAD+ is bond in an extended conformation (i.e. the adenine and nicotinamide moieties are apart), in the present case the substrates must adopt a more ``closed'' conformation, i.e. a nicotinamide-adenine stacked conformation, reminiscent of the form that is found in solution (Reisbig and Woody, 1978; Oppenheimer, 1982). Such a conformation might even be more compact on binding to the active site, inducing some strain, resulting for example in unfavorable nonbonded interactions in the NMN+ moiety, which could be released when going to the transition state and thus explain some of the catalysis in the N-glycosidic bond destabilization.

In conclusion, bovine spleen NAD+ glycohydrolase is a multifunctional enzyme that, similarly to CD38, is involved in the metabolism of cADPR. The low proportion of cADPR formed from NAD+ might be nevertheless high enough to be of physiological significance in Ca2+ signaling (Guse et al., 1995). Importantly, the mechanism we propose for the formation of the cyclic metabolite, which is based on the partitioning of the oxocarbenium reaction intermediate between an intramolecular attack by the N-1 position of adenine and an intermolecular reaction by a water molecule, predicts that small changes in the conformation of the active site of the enzyme might have dramatic consequences on the extent of cyclization. Thus, a nonbonded interaction (``cross-talk'') with a neighboring protein (dimerization or with another receptor) of this ectoenzyme might change the topology of its active site and favor the cyclization reaction.


FOOTNOTES

*   The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Dagger    To whom correspondence should be addressed. Tel.: 33-88-67-68-40; Fax: 33-88-67-88-91; E-mail: schuber{at}pharma.u-strasbg.fr.
1   The abbreviations used are: cADPR, cyclic ADP-ribose; NGD+, nicotinamide guanine dinucleotide; cGDPR, cyclic GDP-ribose; CHAPS, 3-[(3-cholamidopropyl)dimethylammonio]-2-hydroxy-1-propane-sulfonate; HPLC, high-performance liquid chromatography.
2   The reaction conditions were similar to those that were used for the nonenzymatic solvolysis of NAD+ and that yield a mixture of alpha - and beta -methyl ADP-ribose (Tarnus et al., 1988). In analogy with NAD+, the enzymatic methanolysis of NGD+ presumably yields the beta -methyl GDP-ribose isomer; this point remains, however, to be verified.
3   The partitioning ratio is defined (Tarnus et al., 1988) by the ratio:
K=<FR><NU><UP>methyl GDP</UP>-<UP>ribose</UP></NU><DE><UP>GDP-ribose</UP></DE></FR>×<FR><NU><UP>H</UP><SUB>2</SUB><UP>O</UP></NU><DE><UP>CH</UP><SUB>3</SUB><UP>OH</UP></DE></FR> (Eq. 1Eq.)

4   Formally, the positive charge is delocalized over the N-7 and N-9 positions. Analysis by HPLC of the hydrolytic product(s) revealed a single peak, but we have not determined the nature of the bond, i.e. N(7)-C(1)' or N(9)-C(1)", that is prevalently hydrolyzed.
5   It should be noted that within the active site of the enzyme, the ADP-ribosyl oxocarbenium ion might not be a single species with regard to the configuration of the adenine-ribose bond. Thus, when generated from NAD+, its methanol/water partitioning ratio is 50 (which might be an average value for the different conformers), whereas when generated from cADPR, this ratio drops to 30 (Muller-Steffner et al., 1994), indicating that an oxocarbenium ion generated from a species where the adenine has exclusively a syn configuration is less stabilized by the active site.

Acknowledgments

We thank Norman Oppenheimer and Neil Buckley for stimulating discussions.


REFERENCES

  1. Amar-Costesec, A., Prado-Figueroa, M., Beaufay, H., Nagelkerke, J. F., Van Berkel, T. J. C. (1985) J. Cell Biol. 100, 189-197 [Abstract/Free Full Text]
  2. Bell, C. E., Eisenberg, D. (1996) Biochemistry 35, 1137-1149 [CrossRef][Medline] [Order article via Infotrieve]
  3. Beranek, D. T., Weis, C. C., Swenson, H. (1980) Carcinogenesis 1, 595-606 [Abstract/Free Full Text]
  4. Bocchini, V., Rebel, G., Massarelli, R., Schuber, F., Muller, C. D. (1988) Int. J. Dev. Neurosci. 6, 525-534 [CrossRef][Medline] [Order article via Infotrieve]
  5. Brown, D. M. (1974) Basic Principles in Nucleic Acid Chemistry (Ts'o, P. O. P., eds) , Vol 2, p. 1, Academic Press, New York
  6. Funaro, A., Horenstein, A. L., and Malavasi, F. (1995) Fundam. Clin. Immunol. 3, 101-113
  7. Graeff, R. M., Walseth, T. F., Fryxell, K., Branton, W. D., Lee, H. C. (1994) J. Biol. Chem. 269, 30260-30267 [Abstract/Free Full Text]
  8. Graeff, R. M., Walseth, T. F., Hill, H. K., Lee, H. C. (1996) Biochemistry 35, 379-386 [CrossRef][Medline] [Order article via Infotrieve]
  9. Guse, A. H., da Silva, C. P., Emmrich, F., Ashamu, G. A., Potter, B. V. L., Mayr, G. W. (1995) J. Immunol. 155, 3353-3359 [Abstract]
  10. Handlon, A. L., Xu, C., Muller-Steffner, H. M., Schuber, F., Oppenheimer, N. J. (1994) J. Am. Chem. Soc. 116, 12087-12088 [CrossRef]
  11. Hellmich, M. R., Strumwasser, F. (1991) Cell Regul. 2, 193-202 [Medline] [Order article via Infotrieve]
  12. Hirata, Y., Kimura, N., Sato, K., Ohsugi, Y., Takasawa, S., Okamoto, H., Ishikawa, T., Ishihara, K., Hirano, T. (1994) FEBS Lett. 356, 244-248 [CrossRef][Medline] [Order article via Infotrieve]
  13. Howard, M., Grimaldi, J. F., Bazan, J. F., Lund, F. E., Santos-Argumedo, L., Parkhouse, R. M. E., Walseth, T. F., Lee, H. C. (1993) Science 262, 1056-1059 [Abstract/Free Full Text]
  14. Jones, J. W., Robins, R. K. (1963) J. Am. Chem. Soc. 85, 193-201 [CrossRef]
  15. Kim, H., Jacobson, E. L., Jacobson, M. K. (1993a) Science 261, 1330-1333 [Abstract/Free Full Text]
  16. Kim, H., Jacobson, E. L., Jacobson, M. K. (1993b) Biochem. Biophys. Res. Commun. 194, 1143-1147 [CrossRef][Medline] [Order article via Infotrieve]
  17. Knowles, J. R. (1965) Biochem. J. 95, 180-190 [Medline] [Order article via Infotrieve]
  18. Lee, H. C. (1994) Mol. Cell. Biochem. 138, 229-235 [CrossRef][Medline] [Order article via Infotrieve]
  19. Lee, H. C., Aarhus, R. (1991) Cell Regul. 2, 203-209 [Medline] [Order article via Infotrieve]
  20. Lee, H. C., Galione, A., Walseth, T. F. (1994) Vitamins and Hormones (Litwack, G., eds) , Vol 48, p. 199, Academic Press, Orlando, FL
  21. Lee, H. C., Graeff, R., Walseth, T. F. (1995) Biochimie (Paris) 77, 354-355
  22. Lund, F., Solvason, N., Grimaldi, J. C., Parkhouse, R. M. E., Howard, M. (1995) Immunol. Today 16, 469-473 [CrossRef][Medline] [Order article via Infotrieve]
  23. Malavasi, F., Funaro, A., Roggero, S., Horenstein, A., Calosso, L., Mehta, K. (1994) Immunol. Today 15, 95-97 [CrossRef][Medline] [Order article via Infotrieve]
  24. Masmoudi, A., Mandel, P. (1987) Biochemistry 26, 1965-1969 [CrossRef][Medline] [Order article via Infotrieve]
  25. Muller-Steffner, H., Schenherr-Gusse, I., Tarnus, C., Schuber, F. (1993) Arch. Biochem. Biophys. 304, 154-162 [CrossRef][Medline] [Order article via Infotrieve]
  26. Muller-Steffner, H., Muzard, M., Oppenheimer, N., Schuber, F. (1994) Biochem. Biophys. Res. Commun. 204, 1279-1285 [CrossRef][Medline] [Order article via Infotrieve]
  27. Oppenheimer, N. J. (1982) The Pyridine Nucleotide Coenzymes (Everse, J., Anderson, B., You, K.-S., eds) , p. 51, Academic Press, New York
  28. Price, S. R., Pekala, P. H. (1987) Pyridine Nucleotide Coenzymes: Chemical, Biochemical, and Medical Aspects (Dolphin, D., Poulson, R., Avramovic, O., eds) , Vol 2B, p. 513, John Wiley & Sons, Inc., New York
  29. Reisbig, R. R., Woody, R. W. (1978) Biochemistry 17, 1974-1984 [CrossRef][Medline] [Order article via Infotrieve]
  30. Rossmann, M. G., Liljas, A., Bränden, C.-I., Banaszak, L. J. (1975) Enzymes 11, 61-102
  31. Schuber, F., Travo, P., Pascal, M. (1976) Eur. J. Biochem. 69, 593-602
  32. Schuber, F., Travo, P., Pascal, M. (1979) Bioorg. Chem. 8, 83-90
  33. Singer, B. (1975) Progress in Nucleic Acid Research and Molecular Biology (Cohen, W. E., eds) , Vol 15, p. 219, Academic Press, New York
  34. States, D. J., Walseth, T. F., Lee, H. C. (1992) Trends Biochem. Sci. 17, 495 [Medline] [Order article via Infotrieve]
  35. Tarnus, C., Schuber, F. (1987) Bioorg. Chem. 15, 31-42 [CrossRef]
  36. Tarnus, C., Muller, H. M., Schuber, F. (1988) Bioorg. Chem. 16, 38-51 [CrossRef]
  37. Yost, D. A., Anderson, B. M. (1983) J. Biol. Chem. 258, 3075-3080 [Abstract/Free Full Text]
  38. Zhang, F.-J., Sih, C. J. (1995) Tetrahedron Lett. 36, 9289-9292 [CrossRef]
  39. Zocchi, E., Franco, L., Guida, U., Benatti, A., Bargellesi, A., Malavasi, F., Lee, H. C., De Flora, A. (1993) Biochem. Biophys. Res. Commun. 196, 1459-1465 [CrossRef][Medline] [Order article via Infotrieve]

©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
S. Ma, R. Subramanian, Y. Xu, M. Schrag, and M. Shou
Structural Characterization of Novel Adenine Dinucleotide Phosphate Conjugates of Imatinib in Incubations with Rat and Human Liver Microsomes
Drug Metab. Dispos., December 1, 2008; 36(12): 2414 - 2418.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Q. Liu, I. A. Kriksunov, R. Graeff, C. Munshi, H. C. Lee, and Q. Hao
Structural Basis for the Mechanistic Understanding of Human CD38-controlled Multiple Catalysis
J. Biol. Chem., October 27, 2006; 281(43): 32861 - 32869.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. D. Jackson, M. T. Schmidt, N. J. Oppenheimer, and J. M. Denu
Mechanism of Nicotinamide Inhibition and Transglycosidation by Sir2 Histone/Protein Deacetylases
J. Biol. Chem., December 19, 2003; 278(51): 50985 - 50998.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Munshi, D. J. Thiel, I. I. Mathews, R. Aarhus, T. F. Walseth, and H. C. Lee
Characterization of the Active Site of ADP-ribosyl Cyclase
J. Biol. Chem., October 22, 1999; 274(43): 30770 - 30777.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. E. Lund, H. M. Muller-Steffner, N. Yu, C. D. Stout, F. Schuber, and M. C. Howard
CD38 Signaling in B Lymphocytes Is Controlled by Its Ectodomain but Occurs Independently of Enzymatically Generated ADP-Ribose or Cyclic ADP-Ribose
J. Immunol., March 1, 1999; 162(5): 2693 - 2702.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. A. Cockayne, T. Muchamuel, J. C. Grimaldi, H. Muller-Steffner, T. D. Randall, F. E. Lund, R. Murray, F. Schuber, and M. C. Howard
Mice Deficient for the Ecto-Nicotinamide Adenine Dinucleotide Glycohydrolase CD38 Exhibit Altered Humoral Immune Responses
Blood, August 15, 1998; 92(4): 1324 - 1333.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Munshi, R. Aarhus, R. Graeff, T. F. Walseth, D. Levitt, and H. C. Lee
Identification of the Enzymatic Active Site of CD38 by Site-directed Mutagenesis
J. Biol. Chem., July 7, 2000; 275(28): 21566 - 21571.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Muller-Steffner, H. M.
Right arrow Articles by Schuber, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Muller-Steffner, H. M.
Right arrow Articles by Schuber, F.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement